Soch Finance

Call Directions Website Contact the business

Soch Finance SEBI Registered Research Analyst - INH000021650 | Equity Research | Market Insights | Investor Education | Simplifying Finance | Welcome to Soch Finance. No.

I, Isha Jain is a SEBI Registered Research Analyst (Reg. INH000021650). At Soch Finance, we share Equity Research, Market Insights, and Financial Education to help investors make informed decisions.

⚠️ Disclaimer: All content shared here is for educational and informational purposes only. It should not be considered investment advice or a recommendation to buy/sell securities. Please refer to full disclosures at sochfinance.com.

22/10/2026
19/10/2026

🚗 Tiger Shroff Firing Incident: Will Car Insurance Pay for the Damage?

What if your car gets damaged during a protest, someone throws a stone at your windshield, or a tree falls on your parked car? Will your insurance company pay, or will you have to bear the cost yourself?

The answer depends on your insurance policy! 👇

🔹 Third-party insurance: Generally does not cover damage to your own car.

🔹 Comprehensive or own-damage insurance: May cover the damage, depending on the incident and policy terms.

🔹 Riot or vandalism damage: Check whether the relevant risks are covered under your policy.

🔹 Accidental damage: Coverage depends on the circumstances and applicable policy conditions.

✅ Remember: Having comprehensive insurance does not guarantee approval of every claim. Read the exclusions, take photographs of the damage, report the incident to the police where appropriate, and inform your insurer promptly.

📌 Save this Reel before your next car insurance renewal. Don't just compare premiums—understand what your policy actually covers!

💻 Follow Isha Jain & Soch Finance to level up your investment journey.

✒️ I write to simplify & for retail investors.

Disclaimer: I am a SEBI Registered Research Analyst. This post is for educational and informational purposes only and does not constitute investment advice or a recommendation. Investors should conduct their own due diligence before making investment decisions.

The coverage distinctions above are based on IRDAI’s explanation of own-damage versus third-party insurance and published guidance on riot damage and road debris. Actual claim decisions depend on the policy and circumstances.

18/10/2026

Small money. Smart strategy. Bigger business? 🥚💰

What can one chicken teach you about business and finance?

This simple egg-selling story explains 3 powerful concepts: Organic Growth, Lease Financing, and Leverage, and how entrepreneurs can use limited capital to scale a business.

The biggest lesson? It’s not just about how much money you have, but how you use your resources, cash flow, and financing to grow.

⚠️ Remember: Leverage can amplify losses too, and revenue isn’t the same as profit.

Share this Reel with a friend who wants to start a business!

Follow Soch Finance for business lessons, financial concepts, and real market insights, not noise.

16/10/2026

Tesla is pushing the boundaries of electric cars and futuristic technology! 🚗From extreme acceleration to bold innovations, Elon Musk’s vision for the future of mobility continues to spark debate.

Is this the future of automobiles, or is the technology getting a little too futuristic? 👀

Comment your thoughts and share this Reel with a friend who loves cars and tech!

Follow for real market insights, business stories and tech updates — not noise.

16/10/2026

SEBI revises the Closing Auction Session (CAS) rules! 📊

From December 7, 2026, the revised framework changes the CAS timing to 3:30–3:40 PM and uses the 3:00–3:30 PM VWAP—not the closing auction price—to calculate expiry-day settlement prices for index and stock derivatives.

Could this support trading activity and benefit stock exchanges like NSE and BSE, along with brokerage firms? It’s a possibility, not a guarantee.

What’s your take on SEBI’s revised rules? Comment below and share this with an F&O trader.

Follow Soch Finance for real market insights, not noise.

15/10/2026

**From Free Internet to a ₹10 Lakh Crore IPO Story — The Journey of Reliance Jio 🚀**

In 2016, Reliance Jio entered India’s telecom market with free voice calls and introductory free data offers, disrupting the industry and changing how millions of Indians accessed the internet.

From affordable mobile data and massive network expansion to investments from global giants like Meta and Google, Jio gradually evolved beyond telecom into a broader digital ecosystem spanning broadband, enterprise services, digital platforms and 5G.

By March 2026, its telecom subsidiary had more than 524 million customers. Now, Jio Platforms is preparing for its next major chapter: an IPO.

And the story gets even more interesting as satellite internet competition grows, with Starlink also seeking to establish its presence in India.

But this isn’t an IPO recommendation. It’s the story of an Indian business that transformed the digital landscape and is now entering a new phase of growth.

📤 Share this Reel with someone waiting for the Jio IPO.

Follow for business stories, IPO analysis and real market insights — not noise.

14/10/2026

Jio IPO: Is a ₹10.3 Lakh Crore Valuation Worth It?

Mukesh Ambani’s Jio Platforms is preparing for a much-awaited IPO, with a reported valuation of around ₹10.3 lakh crore and an expected fundraising target of approximately ₹30,000 crore.

But there’s another story investors are watching: Elon Musk’s Starlink and its plans to enter India’s satellite internet market.

The recent Starlink controversy has brought competition, regulation and the future of satellite internet in India into the spotlight.

Jio is already a major player in India’s telecom market, with businesses spanning mobile connectivity, broadband and digital services. Satellite internet could also be an important market to watch as competition evolves.

But here’s the real investor question: Can Jio’s future growth justify its reported IPO valuation?

A strong brand and a popular IPO don’t automatically mean an attractive investment. Investors should examine the final issue price, financial performance, profitability and valuation before making a decision.

📌 Follow as we break down the Jio IPO, its valuation and the business opportunities investors should watch.

📤 Share this Reel with someone waiting for the Jio IPO.

💬Would you consider investing in Jio IPO? Tell us in the comments.

13/10/2026

Nifty IT Surges Over 5%: Is the IT Sector Making a Comeback? 📈

Indian IT stocks rallied sharply today, with Nifty IT rising over 5% and HCLTech and TCS leading the move. The major trigger? HCLTech’s Q2 FY27 results.

Here are the key numbers investors should know:

📊 Net Profit: ₹5,132 crore, up 21.2% YoY
📈 Revenue: ₹35,620 crore, up 11.5% YoY
💰 Operating Margin: Improved from 16.9% to 18.2% QoQ
🤝 New Deal Bookings: $3.26 billion, up 27% YoY
🤖 Advanced AI Revenue: Grew 78% YoY in constant currency

HCLTech’s stronger margins, deal bookings and AI growth helped boost investor sentiment. HCLTech shares rose around 8.4%, while TCS gained approximately 6.8% during the session.

However, there’s still a factor to watch: HCLTech raised the lower end of its FY27 revenue growth guidance from 1% to 2.5%, while keeping the upper end at 4%.

Does this rally signal a sustained IT sector recovery, or is it too early to call a comeback? The upcoming IT results and follow-through buying will be important to watch.

🔖 Save this Reel to track the IT sector during earnings season.
💬 Comment below: IT comeback or wait and watch?

12/10/2026

Can medicine price controls impact hospital stocks?

A cancer medicine bought by a retailer for ₹2,700 reportedly had an MRP of ₹27,000. Now, the Supreme Court is questioning why medicine price controls should remain limited to cancer drugs and whether broader regulation should be considered.

Following concerns over high medicine markups, the government introduced a 30% trade margin cap on non-scheduled anti-cancer medicines. However, a broader price-control framework has not been implemented across all medicines.

The Centre argues that Indian medicine prices are already relatively low globally and that any additional controls must balance affordability with medicine availability.

Meanwhile, hospital stocks came under pressure, with Apollo Hospitals, Max Healthcare, Fortis Healthcare and Park Medi World witnessing declines during the trading session.

📉 What could this mean for investors?
If medicine price controls expand in the future, hospital pharmacies and pharmaceutical companies could face pressure on medicine-related margins. The actual impact will depend on the final rules and each company's business mix.

The key question is: Can medicines become more affordable without disrupting supply or hurting business margins?

💬 Do you think the government should extend medicine margin caps to all medicines?

🔖 Save this Reel to track future developments in hospital stocks, pharmaceutical stocks and drug pricing regulations.

Follow for stock market news, business updates and investor-focused analysis.

Address

Delhi

Alerts

Be the first to know and let us send you an email when Soch Finance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Soch Finance:

Shortcuts

Share